Comparison of MS clinical phenotypes using conventional and magnetization transfer MRI

被引:200
作者
Filippi, M
Iannucci, G
Tortorella, C
Minicucci, L
Horsfield, MA
Colombo, B
Sormani, MP
Comi, G
机构
[1] Univ Milan, Sci Inst Osped San Raffaele, Dept Neurosci, Neuroimaging Res Unit, I-20132 Milan, Italy
[2] Univ Milan, Sci Inst Osped San Raffaele, Dept Neurosci, Clin Trials Unit, I-20132 Milan, Italy
[3] Inst Canc Res, Unit Clin Epidemiol & Trials, Genoa, Italy
[4] Univ Leicester, Div Med Phys, Leicester LE1 7RH, Leics, England
关键词
D O I
10.1212/WNL.52.3.588
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: To identify differences in pathology between the principal clinical phenotypes of MS using conventional and magnetization transfer (MT) MRI. Methods: T1-weighted and T2-weighted images as well as MT scans were obtained from 20 controls, 21 patients presenting with clinically isolated syndromes suggestive of MS, and 93 MS patients with relapsing-remitting secondary progressive, benign, or primary progressive course. Metrics considered: hypointense T1 and T2 lesion volumes, average lesion MT ratio, average brain MT ratio, peak height and position from MT histograms. Results: MS patients had lower MT metrics than controls. Patients with clinically isolated syndromes had MT measures similar to controls, whereas primary progressive MS patients had lower histogram peak height with normal peak position. Relapsing-remitting MS patients had lower MT measures, higher T2 lesion load and ratio of hypointense T1 to T2 lesion volumes than patients with clinically isolated syndromes, and lower MT ratio and peak height than benign MS patients. Benign MS patients were similar to controls and patients with clinically isolated syndromes. Secondary progressive MS patients had the lowest MT measures and highest lesion loads. Conclusions: Pathology in patients with clinically isolated syndromes is confined to modest tissue damage in the lesions seen on T2-weighted scans. Severe damage is important for the later development of disability. However, microscopic damage in normal-appearing white matter may be a major contributor to disability in primary progressive MS.
引用
收藏
页码:588 / 594
页数:7
相关论文
共 38 条
  • [21] Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis
    Miller, DH
    Albert, PS
    Barkhof, F
    Francis, G
    Frank, JA
    Hodgkinson, S
    Lublin, FD
    Paty, DW
    Reingold, SC
    Simon, J
    [J]. ANNALS OF NEUROLOGY, 1996, 39 (01) : 6 - 16
  • [22] MAGNETIC-RESONANCE-IMAGING IN MONITORING THE TREATMENT OF MULTIPLE-SCLEROSIS - CONCERTED ACTION GUIDELINES
    MILLER, DH
    BARKHOF, F
    BERRY, I
    KAPPOS, L
    SCOTTI, G
    THOMPSON, AJ
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1991, 54 (08) : 683 - 688
  • [23] THE SIGNIFICANCE OF BRAIN MAGNETIC-RESONANCE-IMAGING ABNORMALITIES AT PRESENTATION WITH CLINICALLY ISOLATED SYNDROMES SUGGESTIVE OF MULTIPLE-SCLEROSIS - A 5-YEAR FOLLOW-UP-STUDY
    MORRISSEY, SP
    MILLER, DH
    KENDALL, BE
    KINGSLEY, DPE
    KELLY, MA
    FRANCIS, DA
    MACMANUS, DG
    MCDONALD, WI
    [J]. BRAIN, 1993, 116 : 135 - 146
  • [24] Imaging of axonal damage in multiple sclerosis: Spatial distribution of magnetic resonance imaging lesions
    Narayanan, S
    Fu, L
    Pioro, E
    DeStefano, N
    Collins, DL
    Francis, GS
    Antel, JP
    Matthews, PM
    Arnold, DL
    [J]. ANNALS OF NEUROLOGY, 1997, 41 (03) : 385 - 391
  • [25] Brain and spinal cord abnormalities in multiple sclerosis - Correlation between MRI parameters, clinical subtypes and symptoms
    Nijeholt, GJLA
    van Walderveen, MAA
    Castelijns, JA
    van Waesberghe, JHTM
    Polman, C
    Scheltens, P
    Rosier, PFWM
    Jongen, PJH
    Barkhof, F
    [J]. BRAIN, 1998, 121 : 687 - 697
  • [26] The prognostic value of brain MRI in clinically isolated syndromes of the CNS - A 10-year follow-up
    O'Riordan, JI
    Thompson, AJ
    Kingsley, DPE
    MacManus, DG
    Kendall, BE
    Rudge, P
    McDonald, WI
    Miller, DH
    [J]. BRAIN, 1998, 121 : 495 - 503
  • [27] NEW DIAGNOSTIC-CRITERIA FOR MULTIPLE-SCLEROSIS - GUIDELINES FOR RESEARCH PROTOCOLS
    POSER, CM
    PATY, DW
    SCHEINBERG, L
    MCDONALD, WI
    DAVIS, FA
    EBERS, GC
    JOHNSON, KP
    SIBLEY, WA
    SILBERBERG, DH
    TOURTELLOTTE, WW
    [J]. ANNALS OF NEUROLOGY, 1983, 13 (03) : 227 - 231
  • [28] Intra-observer reproducibility in measuring new putative MR markers of demyelination and axonal loss in multiple sclerosis: A comparison with conventional T2-weighted images
    Rovaris, M
    Filippi, M
    Calori, G
    Rodegher, M
    Campi, A
    Colombo, B
    Comi, G
    [J]. JOURNAL OF NEUROLOGY, 1997, 244 (04) : 266 - 270
  • [29] SERIAL GADOLINIUM-ENHANCED MRI IN RELAPSING REMITTING MULTIPLE-SCLEROSIS OF VARYING DISEASE DURATION
    THOMPSON, AJ
    MILLER, D
    YOUL, B
    MACMANUS, D
    MOORE, S
    KINGSLEY, D
    KENDALL, B
    FEINSTEIN, A
    MCDONALD, WI
    [J]. NEUROLOGY, 1992, 42 (01) : 60 - 63
  • [30] PATTERNS OF DISEASE-ACTIVITY IN MULTIPLE-SCLEROSIS - CLINICAL AND MAGNETIC-RESONANCE-IMAGING STUDY
    THOMPSON, AJ
    KERMODE, AG
    MACMANUS, DG
    KENDALL, BE
    KINGSLEY, DPE
    MOSELEY, IF
    MCDONALD, WI
    [J]. BRITISH MEDICAL JOURNAL, 1990, 300 (6725): : 631 - 634